Welcome to our dedicated page for Qorvo SEC filings (Ticker: QRVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Qorvo filings document material-event disclosures for an operating semiconductor company focused on connectivity and power solutions. The company’s Form 8-K records include furnished earnings releases, preliminary and quarterly operating results, material agreements, governance matters, shareholder-voting disclosures, risk-factor updates, and capital-structure information.
Formal disclosures also cover securities-law communications and related exhibits connected to corporate actions, while financial-condition reports document revenue, gross margin, operating income, and earnings-per-share measures.
Form 144 filing for Qorvo, Inc. (QRVO) notifies the proposed sale of 13,612 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $1,293,140.00. The filing lists the approximate sale date as 09/22/2025 and identifies the securities exchange as NASDAQ. The number of shares outstanding is reported as 92,654,264, providing context for the size of the proposed sale relative to the company's outstanding equity.
The shares being offered were acquired in several restricted stock vesting events from the issuer as compensation on 05/14/2024 (4,309 shares), 11/07/2024 (468 shares), 05/05/2025 (3,689 shares), 05/15/2025 (3,016 shares), and 08/05/2025 (2,130 shares). The filer reports no securities sold during the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Grant Brown, the SVP & Chief Financial Officer of Qorvo, Inc. (QRVO), reported a sale of 5,719 shares of Qorvo common stock on 09/05/2025 at a reported price of $92.20 per share. After this transaction he beneficially owns 64,688 shares directly. The Form 4 was signed by an authorized representative on 09/08/2025.
Qorvo insider Chesley Philip, Senior Vice President, High Performance Analog, reported a sale of 2,664 shares of Qorvo common stock on 08/15/2025 at $90.09 per share under a Rule 10b5-1 trading plan adopted August 5, 2024. After the reported sale the filing shows beneficial ownership of 33,592 shares held directly. The Form 4 was signed under power of attorney on 08/19/2025. No derivative transactions or other classes of securities are reported.
Chris Koopmans, a director of Qorvo, Inc. (QRVO), acquired 2,496 shares of the company on 08/14/2025, increasing his beneficial ownership to 3,833 shares. The Form 4 was filed under Section 16 and signed by an authorized person on 08/15/2025. The reported acquisition shows a price of $0 for the transaction as recorded on the form.
Qorvo, Inc. filed an amended current report to update a prior disclosure about its board of directors. The filing explains that shareholders elected Peter A. Feld as a director at the 2025 annual meeting to serve a one-year term until a successor is elected or he resigns or is removed.
The update also notes that the board later appointed Mr. Feld to the Audit Committee, clarifying his specific committee role. No other parts of the earlier report were changed, and the amendment is limited to these governance details.
Qorvo director Susan Louise Spradley reported an acquisition of 2,496 shares of Qorvo common stock on 08/14/2025 under a Form 4 filing. The report shows the shares were acquired at a price of $0, bringing her total beneficial ownership to 12,024 shares. The Form 4 was executed by Jason T. Gray under power of attorney on 08/15/2025. The filing identifies Spradley as a director and was filed individually.
Rhines Walden C, a director of Qorvo, Inc. (QRVO), reported acquiring 2,496 shares of Qorvo common stock on 08/14/2025 with a reported price of $0. After this transaction the reporting person beneficially owned 71,738 shares. The Form 4 was signed by an authorized representative under power of attorney.
Nelson Roderick, a director of Qorvo, Inc. (QRVO), reported acquiring 2,496 shares of the company’s common stock through a non‑cash transaction (price reported as $0). After the reported acquisition, his beneficial ownership totaled 10,188 shares. The filing indicates this was reported on Form 4 and was submitted by an authorized attorney.
Alan S. Lowe, a director of Qorvo, Inc. (QRVO), reported a non-derivative acquisition on 08/14/2025. The filing shows he acquired 2,496 shares of common stock at a reported price of $0, bringing his direct beneficial ownership to 4,906 shares. The Form 4 was submitted under power of attorney on 08/15/2025.
John R. Harding, a director of Qorvo, Inc. (QRVO), acquired 2,496 shares on 08/14/2025. The Form 4 shows the acquisition was reported with a price of $0 and leaves unchanged an aggregate beneficial ownership of 10,093 shares following the transaction. The filing was signed by an authorized attorney-in-fact on 08/15/2025. No derivative transactions or additional disclosures appear in the form.